HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

IONIS-PKK-LRx

Also Known As:

IONIS-PKK

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleotides: 15763
  - Polynucleotides: 218
    - Oligonucleotides: 5145
      - IONIS-PKK-LRx: 1

Experts

1.	Alexander, Veronica J: 1 article (01/2020)
2.	Baker, Brenda F: 1 article (01/2020)
3.	Cohn, Danny M: 1 article (01/2020)
4.	Fijen, Lauré M: 1 article (01/2020)
5.	Geary, Richard S: 1 article (01/2020)
6.	Kaeser, Gwendolyn E: 1 article (01/2020)
7.	Levi, Marcel: 1 article (01/2020)
8.	Meijers, Joost C M: 1 article (01/2020)
9.	Nanavati, Charvi: 1 article (01/2020)
10.	Schneider, Eugene: 1 article (01/2020)

Related Diseases

1.	Angioedema 01/01/2020 - "In a compassionate-use pilot study, two patients with severe bradykinin-mediated angioedema were initially administered weekly subcutaneous injections of the unconjugated parent drug, IONIS-PKKRx, for 12 to 16 weeks, after which they received IONIS-PKK-LRx at a dose of 80 mg every 3 to 4 weeks for 7 to 8 months. "

Related Drugs and Biologics

1.	Bradykinin

Related Therapies and Procedures

1.	Subcutaneous Injections